본문 바로가기

Data Plus(+)

All 807,818 Page 31,833/80,782

검색

Contents

No Journal_name Subject Date DOI Author
489498 ENVIRONMENT INTERNATIONAL Accelerated oxidation of 2,4,6-trichlorophenol in Cu(II)/H2O2/Cl- system: A unique “halotolerant” Fenton-like process? 2019-11-01 10.1016/j.envint.2019.105128 Wang Zhaohui, Liu Qingze, Yang Fei, Huang Ying, Xue Ying, Yuan Ruixia, Sheng Bo, Wang Xiaoxiao
489497 NEURO-ONCOLOGY ACTR-20. EFFICACY OF INITIAL TEMOZOLOMIDE FOR HIGH-RISK LOW GRADE GLIOMAS IN A PHASE II AINO (ITALIAN ASSOCIATION FOR NEURO-ONCOLOGY) STUDY: A POST-HOC ANALYSIS WITHIN MOLECULAR SUBGROUPS OF WHO 2016 | ACTR-20. EFFICACY OF INITIAL TEMOZOLOMIDE FOR HIGH-RI 2019-11-01 10.1093/neuonc/noz175.063 Rudà Roberta, Pellerino Alessia, Pace Andrea, Maria Carapella Carmine, Dealis Cristina, Caroli Manuela, Faedi Marina, Bello Lorenzo, Migliore Enrica, Marchese Giulia, Bertero Luca, Cassoni Paola, Soffietti Riccardo
489496 NEURO-ONCOLOGY HOUT-04. ASSOCIATION OF COMMON PATIENT-REPORTED IMMUNOTHERAPY SYMPTOMATIC SIDE EFFECTS AND PSEUDOPROGRESSION IN PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS 2019-11-01 10.1093/neuonc/noz175.469 Vyas Yamini, Vera Elizabeth, Bryla Christine, Crandon Sonja, Wu Jing, Wall Kathleen, Theeler Brett, Siegel Christine, Reyes Jennifer, Penas-Prado Marta, Leggiero Nicole, Cordova Christine, Burton Eric, Antony Ramya, Boris Lisa, Aboud Orwa, Gilbert Mark, Armstrong Terri
489495 NEURO-ONCOLOGY CMET-18. IMPACT OF KRAS MUTATION STATUS ON THE EFFICACY OF IMMUNOTHERAPY IN LUNG CANCER BRAIN METASTASES | CMET-18. IMPACT OF KRAS MUTATION STATUS ON THE EFFICACY OF IMMUNOTHERAPY IN LUNG CANCER BRAIN METASTASES 2019-11-01 10.1093/neuonc/noz175.219 Lauko Adam, Ali Assad, Sagar Soumya, Barnett Addison, Li Hong, Chao Samuel, Stevens Glen, Pennell Nathan, Peereboom David, Yu Jennifer, Murphy Erin, Angelov Lilyana, Funchain Pauline, Mohammadi Alireza, Suh John, Barnett Gene, Ahluwalia Manmeet
489494 NEURO-ONCOLOGY EPID-28. WHAT DO PATTERNS OF “UNCLASSIFIED” BRAIN TUMORS TELL US ABOUT INCIDENCE RATES OF NON-MALIGNANT BRAIN TUMORS IN CANADA? | EPID-28. WHAT DO PATTERNS OF “UNCLASSIFIED” BRAIN TUMORS TELL US ABOUT INCIDENCE RATES OF NON-MALIGNANT BRAIN TUMORS IN CANAD 2019-11-01 10.1093/neuonc/noz175.328 Smith Trenton, Walker Emily, Yuan Yan, Davis Faith, Megyesi Joseph
489493 NEURO-ONCOLOGY ATIM-31. SAFETY OF TUMOR-SPECIFIC PEPTIDE VACCINE TARGETING ISOCITRATE DEHYDROGENASE 1 MUTATION IN RECURRENT RESECTABLE LOW GRADE GLIOMA PATIENTS 2019-11-01 10.1093/neuonc/noz175.030 Peters Katherine, Congdon Kendra, Archer Gary, Woodring Sarah, Jaggers Denise, Lipp Eric, Healy Patrick, Herndon James, Soher Brian, Vlahovic Gordana, Johnson Margaret, Randazzo Dina, Desjardins Annick, Friedman Henry, Friedman Allan, Ashley David, Yan Hai, Sampson John
489492 INDIAN HEART JOURNAL : OFFICIAL PUBLICATION OF THE CARDIOLOGICAL SOCIETY OF INDIA Urinary NGAL as Early Prediction Marker for Contrast Induced Nephropathy 2019-11-01 10.1016/j.ihj.2019.11.056 Bhatia A., Sawhney J.P.S.
489491 BMJ OPEN Do Norwegian providers comply with national recommendations when prescribing combined oral contraceptives to starters? A cohort study 2019-11-01 10.1136/bmjopen-2018-027888 Ekman Julie, Skjeldestad Finn Egil
489490 ONCOTARGETS AND THERAPY

TNIP1 Inhibits Proliferation And Promotes Apoptosis In Clear Cell Renal Carcinoma Through Targeting C/Ebpβ

2019-11-01 10.2147/ott.s216138 Yang Yong, Fan Jinhai, Han Shenglu, Li Enyuan
489489 ENVIRONMENT INTERNATIONAL Glomalin-related soil protein enhances the sorption of polycyclic aromatic hydrocarbons on cation-modified montmorillonite 2019-11-01 10.1016/j.envint.2019.105093 Chen Shuang, Sheng Xue, Qin Chao, Waigi Michael Gatheru, Gao Yanzheng